drugset / Trial / NCT03023176
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013
Phase 4
Completed
20 enrolled
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelBasic science
Summary
This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.
Timeline
- Start
- 2013-09
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzone® standard IIV3 | Vaccine | 0.25 ml | Intramuscular |
| Subject | Fluzone® standard IIV3 | Vaccine | 0.5 ml | Intramuscular |